Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Anti-Rheumatics Market
Research and Forecast Report 2022-
Author: Elena Anderson
© 2022 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical,
industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.
Report Description and Highlights
Global Anti-Rheumatics Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled “Anti-Rheumatics Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global anti-rheumatics
market reached a value of US$ 61.1 Billion in 2021.
Rheumatoid arthritis is a chronic, autoimmune disease that affects the joints, articular tissues, and
extra-articular organs. It is a progressive disorder that results in pain, inflammation, stiffness, and
swelling of joints. Anti-rheumatics refer to drugs used to manage different symptoms of rheumatoid
arthritis and modify the course of the disease. They can be administered subcutaneously (SC), orally,